Familial Interstitial Lung Disease Caused by Mutation of the STING1 Gene
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Familial Interstitial Lung Disease Caused by Mutation of the STING1 Gene
Authors
Keywords
-
Journal
Frontiers in Pediatrics
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-08
DOI
10.3389/fped.2020.00543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype
- (2020) S. L. N. Clarke et al. Pediatric Rheumatology
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
- (2019) Stefano Volpi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
- (2017) Jieun Seo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
- (2017) Isabelle Melki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy
- (2016) Sarah L. N. Clarke et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)
- (2016) Cécile Picard et al. CHEST
- Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
- (2016) Justin Chia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Type I interferonopathies in pediatric rheumatology
- (2016) Stefano Volpi et al. Pediatric Rheumatology
- Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies
- (2016) Maroof Hasan et al. PHARMACOLOGICAL RESEARCH
- STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease
- (2015) Nicole Dobbs et al. Cell Host & Microbe
- Familial chilblain lupus caused by an activating mutation in STING
- (2015) N König et al. Pediatric Rheumatology
- STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children
- (2015) F Eroglu et al. Pediatric Rheumatology
- Stimulator of Interferon Genes–Associated Vasculopathy With Onset in Infancy
- (2015) Justine Munoz et al. JAMA Dermatology
- Stimulator of Interferon Genes-Associated Vasculitis of Infancy
- (2015) Ebun Omoyinmi et al. Arthritis & Rheumatology
- Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
- (2014) Nadia Jeremiah et al. JOURNAL OF CLINICAL INVESTIGATION
- STING-Associated Vasculopathy with Onset in Infancy — A New Interferonopathy
- (2014) Yanick J. Crow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review
- (2012) Soumya D. Chakravarty et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Type I interferonopathies: a novel set of inborn errors of immunity
- (2011) Yanick J. Crow Annals of the New York Academy of Sciences
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started